Cybersecurity
,
Data Breach
,
Risk Management
Advanced Threats, the Board and You
Presented by
Lockheed Martin & Cybereason
60 Minutes
As a security leader, if you have been in front of your board to talk about advanced threats, acceptable risk and staying out of the headlines, you know it's not a walk in the park. To convey the challenge, even for the most savvy security executive, requires a complex chess game of technology, business and risk management.
Join a diverse and experienced panel of security leaders for this frank discussion of Advanced Threats, the Board, and You - a rich dialog on the ugly truth of APTs and how to get the board fighting on your side as you battle the cyber war. Register for this session and gain new insights on: Advanced threat intelligence and its impact on your business;
How to build a military-grade strategy to fight virulent threats;
How to have the conversation with your board about the balance between risk and defense.
Beginning with RSA breach, continuing with the Target hack and advancing with the past year's headline news of attacks on Anthem, Sony and TalkTalk, cybersecurity in recent years has become a mainstream discussion topic. And business leaders worldwide have come to accept the grim reality: A destructive breach on their watch could cost them their job.
But it isn't enough just to be aware of the potential business impact of a breach. Security leaders need to be engaging their boards and line-of-business peers on a regular basis to ensure cybersecurity awareness and controls are current and satisfactory.
Yet, how should security leaders start, sustain and measure the results of this dialogue?
Join this panel of veteran leaders for a frank discussion about advanced threats, defense and managing business risks. Through interactive dialogue, understand how your peers currently are dealing with today's top advanced threats, and walk away with new insights and ideas for how to better educate, interact with and win support from your board.
You might also be interested in …
Critiquing FDA Medical Device Cybersecurity Guidance